|

A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China

RECRUITINGSponsored by Fudan University
Actively Recruiting
SponsorFudan University
Started2022-07-01
Est. completion2025-07-01
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06591039

Summary

1. To construct a prospective, multi-center breast cancer treatment cohort in China, and analyze the factors affecting breast cancer diagnosis and treatment. 2. To evaluate the diagnosis and treatment and prognosis of breast cancer among patients in different regions and hospitals.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients with malignant breast tumors must be diagnosed by cytology or histology, and their pathological types include but are not limited to breast carcinoma in situ, invasive carcinoma, and breast sarcoma.

Exclusion Criteria:

* None

Conditions3

Breast CancerBreast NeoplasmsCancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.